Hydromer
Private Company
Funding information not available
Overview
Hydromer is a long-established, privately-held leader in the medical device hydrophilic coatings market, serving as a critical partner to both large and emerging device manufacturers. The company operates on a B2B services and contract manufacturing model, offering a comprehensive suite from R&D and formulation to ISO-certified production and FDA regulatory support. Its recent strategic partnership aims to build a global, future-oriented coating platform integrating UV-curable and thermal-cure systems, positioning it for expanded growth. With a remarkable 98% repeat customer rate, Hydromer's success is built on deep technical expertise, a customer-focused approach, and a proven track record in enabling safer, more effective medical devices.
Technology Platform
Integrated platform for hydrophilic medical device coatings, encompassing proprietary UV-curable and thermal-curable polymer formulations, anti-thrombogenic coatings, application equipment, and process expertise for a wide range of substrates.
Opportunities
Risk Factors
Competitive Landscape
Hydromer competes in a specialized niche against other private coating specialists (e.g., SurModics, Harland Medical Systems, AST Products) and potentially the in-house coating capabilities of large medical device companies. Competition is based on technical performance, reliability, regulatory expertise, and customer service. The announced global platform initiative appears to be a competitive move to offer a more comprehensive, geographically diversified solution than many peers.